Online Trainings and Webinars: Addiction Prevention, Treatment & Recovery 

We know that mental health, especially as it relates to addiction, is more important than ever during these trying and uncertain times. We wanted to provide you with a variety of online trainings and webinars that are particularly relevant for addiction and mental health service providers. These courses, provided by various addiction and mental health organizations around the country, address a variety of topics including specific trainings related to COVID-19 and administering services remotely. We hope you find them helpful and we can't wait to see you next year at the 2021 UVU Conference on Addiction!!

How to Address COVID-19 Across Inpatient, Residential, and Other Non-Ambulatory Care Settings

APA and the National Association for Behavioral Healthcare (NABH) jointly host a recorded discussion with experts working in inpatient, residential, and other non-ambulatory care settings about how they are assessing the current environment and developing new protocols to care for their patients during the COVID 19 crisis. In this presentation, you will hear from experts about how to manage through different types of services, key messages to give to your team leaders, unique challenges for people with SMI, how to approach group therapy, and more. 

 

Watch this Webinar

COVID-19 and Mental Health: Caring for the Public and Ourselves

With the novel Coronavirus (COVID-19) outbreak, there are many who may be feeling emotional distress given the uncertainty around the impact, spread, and scope of the disease. Psychiatrists play an important role in supporting patients' management of any psychosocial issues and responses that may arise from the disease's impact on them, their families, and the community. This free presentation will outline how psychiatrists can support patients, communicate with family members and children, and be a resource to other providers during the COVID-19 outbreak. 

 

Watch this Webinar

The Opioid Epidemic: How Risk Management can Prevent/Reduce Drug-Related Harm

This course will provide information regarding potential liability exposures associated with opioid prescribing and dispensing, and provide suggestions to assist the psychiatrist in managing patients needing opioid/controlled drug medications and preventing potential drug diversion. 

 

Watch this Webinar

Emerging Treatment Strategies for Mood and Anxiety Disorders

"Depression is a common disorder, estimated to affect approximately 350 million people worldwide. Depression is costly and one of the main sources of personal suffering and despite available effective treatments depression, unfortunately, remains often untreated or patients do not respond to conventional treatment approaches. Depression affects people in all communities across the world and is the leading cause of disability worldwide in terms of total years lost. Research has shown that depression is a major factor in attempted/completed suicide. Generalized anxiety disorder (GAD) affects approximately 5.7% of the population and is the most common form of anxiety disorder found in the primary care setting. If left untreated, GAD is associated with increased societal costs and can substantially reduce the quality of life of the individual patient. There are different conventional approaches in the treatment of mood and anxiety disorders, mainly pharmacological treatment and psychotherapy. Although patients benefit from these methods, there are many people who are sufficiently responding to these treatments. In this session, the speakers will talk about different emerging treatments and approaches for mood and anxiety disorders." 

 

Watch this Webinar

Minimizing Risk When Treating Suicidal and Violent Patients

Fair or unfair, the public has charged those working in the mental health field with the task of safeguarding society from violence. This course will assist participants in understanding the general liability exposures associated with caring for potentially violent and/or suicidal patients and to provide practical risk management strategies that can be used right away to help lessen liability exposures. 

 

Watch this Webinar

Risk Management Considerations When Practicing Addiction Psychiatry

Each person with a substance use disorder has unique needs for addiction services; therefore addiction psychiatrists provide services in a variety of settings. This program will identify ethical, policy, legal considerations, and liability exposures, which vary depending on the setting and patient populations, and provide risk management strategies when practicing addiction psychiatry. 

 

Watch this Webinar

Risk Management Considerations When Using Social Media and Technology in Psychiatry

Social media and technology, found everywhere in today's society, is a means of communication, education, entertainment, advertisement, and networking. This presentation looks at how to manage some of the risks associated with using social media and technology when practicing psychiatry, especially related to boundary issues, professionalism, confidentiality, and general standards of care. 

 

Watch this Webinar

ADHD in College Populations - Diagnosing and Dosing in an Era of Diversion

In the United States, 7.2% of undergraduate college students come to college already receiving prescriptions for stimulant medications and many seek care from college mental health providers for a continuation of prescribed medication. The population seeking ADHD treatment for the first time is not homogeneous and requires individualized attention, precluding the use of “one size fits all” prescribing guidelines. Groups posing special challenges include student-athletes, professional students (including medical, dental and law students), and minority student populations. There has also been a rise in the misuse of stimulant medications by college populations, currently reported to be around 17%, with a lifetime prevalence between 8 and 43%. Diversion is widespread, and data show that 62% of college students surveyed receiving stimulants divert their medication. At the same time, risk-taking and illegal behaviors are reduced significantly in the 30 days after a stimulant prescription is filled and the benefit of appropriately dosed stimulant medication for people with ADHD is well-documented. On-campus stimulant misuse is often associated with the drive to achieve the goals valued by parents, teachers, and professional school admissions officers. Students feel unable to sustain attention to dry, dense material and to simultaneously complete multiple assignments while keeping up with activities of daily living. Supplying students with the tools to succeed in academia, both undergraduate and graduate may involve not only prescribing medications, but also helping them individuate from parents, assimilate different cultures, master stress and time management skills, and cope with comorbid diagnoses. Providers treating college students, both within the institutions and in the community, find themselves with the burden of meeting the needs of multiple stakeholders while correctly identifying and treating those in need. In this session, we will review current data, present a balanced perspective, and provide a framework for approaching these complex cases. We will also offer insight into specific student populations and the ethical dilemmas that they present. 

 

Watch this Webinar

Telepsychiatry and Risk Management Considerations

Telemental health, or telepsychiatry, refers to the use of videoconferencing to provide healthcare services remotely and can take place in a variety of settings, including institutions, communities, and patients' offices and/or homes. While the benefits are generally recognized, the legal, regulatory, safety and security considerations, as well as potential liability exposures, may not be as well known. This course will provide an overview of not only these considerations but also risk management strategies and best practices as the field of telepsychiatry evolves. 

 

Watch this Webinar

Vaccines for Opioid Use Disorder: Focusing on the Fentanyl Epidemic

Fentanyl has been the leading cause of opioid overdoses during the last couple of years, and these overdoses are not prevented by methadone, buprenorphine, or naltrexone treatment. However, a vaccine against fentanyl has been able to block fentanyl's analgesic, reinforcing, and respiratory effects in animal models. This vaccine is moving forward FDA approval to be tested in humans. This presentation will discuss the mechanism of acting for fentanyl vaccines in preventing overdoses and abuse through the production of anti-fentanyl antibodies. 

 

Watch this Webinar

The Clinical and Public Health Utility of Mutual Aid Organizations in Addressing Addiction: What Does Science Tell Us?

Twelve-step based treatments and related community mutual-aid organizations, such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA), to which patients are referred, have come under scrutiny and criticism in the press and popular media in recent years being branded as "outdated" and "not evidence-based". Polemical debates have raged, fueled by confusion about the state of the science on these treatment and recovery support approaches or misrepresentation of existing research. This activity will present results from comprehensive, gold-standard, reviews of the scientific clinical literature, investigate the health care cost savings obtainable by implementing mutual-aid facilitation approaches in clinical settings, and discuss the implications for clinical practice, addiction treatment and public health broadly. 

 

Watch this Webinar

Tracking Drug Use Patterns

This presentation will enable participants to better identify drug use patterns across the United States and subsequent treatment responses to some of these emerging drug trends. They will additionally identify more efficacious responses for these trends and for drugs that are often understudied. 

 

Watch this Webinar

Levels of Care in Adolescents with Substance Use Disorders

The transition from childhood to adolescence and subsequently adulthood represents two unique developmental periods with significant changes in social networks and interactions. Increasing attention has been given to the possible disruptions and expected changes of cognitive and psychosocial transitions during these periods. Adolescence and early adulthood are the peak times for initiation of substance use disorders (SUD), particularly tobacco, marijuana, prescription drugs, and alcohol. The health care provider’s capacity to respond appropriately to substance use disorders in adolescents is limited at best. Adolescents are particularly vulnerable to the high risk for serious complications of illicit SUD, which include overdose, death, suicide, HIV, and hepatitis C. Both medication-assisted treatment and evidence-based SUD counseling are available but underused in this vulnerable population. In addition, access to developmentally appropriate treatment strategies is restricted for adolescents and young adults, making effective treatment out of reach for this group. This presentation discusses considerations for determining the level of care for adolescents with substance use disorders and the use of behavioral approaches for the treatment of adolescents with or at risk for substance use disorders. 

 

Watch this Webinar

Central Appalachia and the Opioid Epidemic

Since President Nixon declared the War on Drugs in 1971, substance use has been a focus of United States political and public health concerns. Attempts to understand the opiate epidemic have repeatedly engaged with constructions of multiple “cultures”: Appalachian culture, substance use culture, psychiatric/health care culture, and political policy culture. In this CME module, we will explore and critique the various “cultures” deemed integral to the opiate epidemic in Appalachia and the larger ways these cultures encompass understandings of Appalachian mental health. 

 

Watch this Webinar

Recovery Support for Young People with Opioid Use Disorders

This presentation will review recovery supports in addition to the medication that can be considered as part of the treatment plan for young people with an opioid use disorder. These treatment components include family involvement, school-based recovery programs, and mutual help groups. 

 

Watch this Webinar

Comorbidity of Marijuana and Mental Health

American society is highly ambivalent about marijuana use. Some hold that marijuana is a harmless substance that should be legalized, while others believe it may confer therapeutic benefit for patients with certain illnesses. Others have serious concerns about the potential for addiction and the worsening of mental health. Despite society’s equivocal stance, many states have passed or are moving forward with legislation on medical marijuana programs and some states are outright legalizing marijuana, even though such state legislation conflicts with federal law. While the debate within society continues, controversy within the medical community persists as well. Accumulating evidence from psychiatry implicates marijuana use, especially in adolescence, as a risk factor for poor educational achievement, cannabis and other substance use disorders, and psychotic disorders. This, in light of increasing marijuana use, complicates the discourse on legalization. The relevance of this topic is further confirmed by controversy over the “gateway drug” hypothesis and many recent peer-reviewed articles on the effects of marijuana on mental health. This presentation provides a comprehensive overview of the comorbidities of marijuana use and mental disorders through the review and discussion of current research, statistics, and theories associated with marijuana use and mental illness. 

 

Watch this Webinar

innovative Methods for Addressing Substance Use in Pregnancy

Substance use in pregnancy is common and may have adverse impacts on pregnancy outcomes. This webinar will summarize the prevalence of prenatal substance use, potential adverse impacts on the outcome, and identify two new efforts to improve identification and modification of prenatal substance use. 

 

Watch this Webinar

PTSD, Chronic Pain, and Opioid Use Disorder: A Case Discussion

Treating patients with co-occurring chronic, non-cancer pain, and opioid use disorder can be difficult. Adding PTSD to this clinical picture can be even more challenging. The prevalence of chronic pain is higher in patients with PTSD than those without with one VA study showing co-occurring chronic pain in 66% of patients suffering from PTSD (Shipherd et al 2007). It is no surprise since patients with PTSD have more risk factors for pain including higher rates of other psychiatric conditions, medical conditions, and substance use disorders. Further, patients with PTSD report greater pain severity, greater pain related impairment, are more likely to be prescribed opioid medications for chronic pain and are more likely to have opioid use disorders than patients without PTSD. Patients with PTSD also report higher levels of maladaptive coping and beliefs about pain than those with chronic pain alone. In the following case based webinar, we will discuss the challenges in treating this population while describing approaches which may help providers improve the care of these patients.  

 

Watch this Webinar

Pain and Addiction: A Clinical Path to Mindfulness

"The following key points will be addressed in this online clinical vigenette: Substance use disorders have a high co-morbid rate of mental illness. Chronic pain requires a holistic assessment and treatment approach. Pharmacological treatment of substance use disorders can potentially address pain as well. Mindfulness can contribute to the reduction of pain and overall improved mental health."  

 

Watch this Webinar

Managing Active Injection Opioid Use: Severe Depression and Acute Pain

The intersection of active illicit opioid use, acute pain, and severe mental illness can be particularly challenging for generalist clinicians on the inpatient service. This case discussion reviews several options for managing pain in patients with active opioid use disorder on the inpatient medical service. The case provides a discussion of the issues that the healthcare team faces when treating patients with depression and chronic suicidality and provides an expert opinion on managing these psychiatric comorbidities in a patient with comorbid substance use disorder. Finally, it highlights some of the practical challenges and approaches that arise in treating patients with comorbid mental illness, opioid use disorder, and pain on the medical inpatient service.  

 

Watch this Webinar

Using the Echo Model to Expand Access to Treatment of Substance Use Disorders

Many primary care patients have behavioral health (BH) and substance use disorders (SUDs), yet PCPs are inadequately trained in caring for these conditions. Project ECHO aims to develop capacity to effectively treat common, complex diseases in rural and underserved areas. The ECHO model uses videoconferencing to simultaneously connect multiple PCPs with a team of academic specialists and builds PCPs’ capacity via mentorship and case-based learning. The Integrated Addictions and Psychiatry (IAP) TeleECHO Clinic was established in NM in 2005 to expand access to evidence-based treatment for BH and SUDs. This presentation will describe the ECHO experience with SUDs and the recent replication of teleECHO programs for SUDs in several states and countries. We will describe the steps involved in launching an ECHO program to expand access to SUD treatment.  

 

Watch this Webinar

Addiction, Overdose, and Suicide: Preventing Deaths From Drug Self-Intoxication

In the United States, deaths due to opioid overdose (prescription opioid and heroin) have increased 200% since 2000, approximating death rates due to pneumonia and influenza. Deaths due to sedative-hypnotic overdose have quadrupled since 1996. Suicides increased approximately 30% since 2000—not accounting for substance-related poisonings having a component of intentional self-harm but coded as unintentional or undetermined cause due to the absence of a suicide note and other corroborative evidence. Emerging national data suggest significant suicidality associated with substance and prescription overdose, indicating that clinicians are missing critical opportunities for prevention of premature mortality. This webinar will review the proposed death sub-category, “death from drug self-intoxication,” as a surveillance strategy for improving accurate detection of a preventable death. Clinical translations of this concept, including empirical opportunities to elicit self-harm/suicide risk and to intervene with patients and families seeking treatment in a variety of clinical practice settings, will be presented.  

 

Watch this Webinar

Managing Pain in the Setting of Co-morbid Substance Use Disorder

Clinicians are challenged daily with managing both acute and chronic pain in individuals with substance use disorder. The presenters will describe the challenges and opportunities to manage pain in this population both in the acute care environment and in the ambulatory environment. Using a case based approach the presenter will describe options for managing both acute and chronic pain for patients taking methadone, buprenorphine, or naltrexone for the treatment of opioid use disorder as well as those who are still engaged in substance use and those in remission, not currently taking medications. 

 

Watch this Webinar

The Intersection of Problematic Gambling and Opioid Use Disorder

Problematic gambling and gambling disorder are common and more common in individuals with substance use disorders, especially those with opioid use disorder. In addition, many treatment programs do not screen patients for problematic gambling and are not aware of resources available for those who screen positive. Underlying problematic gambling can cause complications in and of itself or can negatively impact treatment and recovery from other substance use disorders. Clinicians can learn to screen individuals and provide them with useful resources. 

 

Watch this Webinar

Telemedicine-Delivered Buprenophine Treatment in the Age of COVID-19

"There are not enough treatment providers to meet the needs of the COVID-19 pandemic and with social distancing, it is critical to minimize the number of face-to-face contacts at the same time as continuing critical treatment for our patients with OUD. Telemedicine can increase access to patients who require ongoing substance use disorder treatment. However, there are numerous regulatory, logistical and other clinical questions, which are also rapidly changing, around implementing telemedicine delivery of medication treatment for OUD (tele-MOUD). In this presentation, we will: present evidence on tele-MOUD but focus most of the discussion on clinical considerations in using implementing telemedicine to deliver quality buprenorphine treatment. The audience will be introduced to tele-MOUD through an interactive facilitated discussion in which audience members will discuss their perceptions, questions and experiences in implementing tele-MOUD. This will be focused on practical clinical concerns around requirements and what works and doesn’t work. We will discuss patient cases related to OUD and associated clinical issues will be presented in order to guide the audience interactively through consideration of treatment options, and how tele-MOUD can play a role depending on the local resources or legal environment. Finally, there will be a discussion of overcoming barriers and challenges to implementing telemedicine delivered treatment. We will address the latest state and federal level legal requirements including discussion of recent changes in regulation." 

 

Watch this Webinar

Recovery Oriented Systems of Care 101 for Prescribers

While the use of medications and behavioral therapy are hallmarks of addiction treatment, more services are needed to facilitate lasting recovery. Recovery-oriented systems of care (ROSC) are a shift away from crisis-oriented, deficit-focused, and professionally-directed models of care to a vision of care that is designed in collaboration with people in recovery, emphasizes the hope and reality of long-term recovery, and recognizes the many pathways to healing for people with mental and substance use disorders . This webinar will explore the ROSC model and discuss how prescribers, peers and other allied professionals can work together to implement ROSC models to facilitate long-term recovery and wellness. 

 

Watch this Webinar

Long-Acting Buprenorphine Treatment for Opioid Use Disorder

Lack of knowledge about available long-acting buprenorphine formulations has led their under-utilization in the health care system, despite large unmet treatment needs among those with opioid use disorder. A multi-disciplinary approach that includes the collaboration between nurse practitioners, PAs, physicians, psychologists, social workers, and hospital administrators is necessary to address this gap in knowledge and provide evidence-based care to those with opioid use disorder. Several newly approved long-acting buprenorphine formulations give patients and providers new options to consider. This webinar will review the peer-reviewed publications from three FDA-approved long-acting products, their FDA-approved indications, practical information on how to use them in clinical practice, ongoing NIDA clinical trials employing these long-acting medications, and patient case scenarios. 

 

Watch this Webinar

The Connection Between Mental Health and Opioid Use Disorder

There is a high prevalence of mental health disorders among those with opioid use disorder. However, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD. 

 

Watch this Webinar

2019 Pain Care Legislation and Public Policy

This webinar will provide insights into state and federal legislation and regulation, and how recent changes in policy will affect people with pain and the healthcare providers who treat them. 

 

Watch this Webinar

Opioid Overdoses, Suicide, and Other Related Syndemics

The purpose of this webinar is to describe the “opioid epidemic” as a complex phenomenon that consists of multiple, related conditions that cluster and interact synergistically to exacerbate health effects, problem severity, and disease progression. 

 

Watch this Webinar

Listening Sessions Summary: COVID-19 Impact on Prevention Practitioners

"In response to new challenges experienced by the prevention workforce resulting from the COVID-19 pandemic, the Pacific Southwest Prevention Technology Transfer Center (PTTC) facilitated four listening sessions over video conference with 111 prevention practitioners joining. Listening sessions were conducted at various times throughout the day on April 15, 16, 21, and 22. Participants represented Arizona, California, Guam, Hawaii, Nevada, and the Republic of the Marshall Islands, as well as a few participants from outside of the Pacific Southwest region. The listening sessions opened up a conversation about the specific challenges practitioners are facing with doing their work in prevention; what training and resources the PTTC could provide to address these challenges; and where are they finding new opportunities for their work. During the listening sessions, spontaneous peer-sharing and crowdsourcing of resources naturally occurred. This document briefly summarizes the conversations held across these four sessions and includes various links to resources as they relate to various topics that emerged during these conversations." 

 

Watch this Webinar

Self-Care in a Selfless Field Presentation and Resources

We are currently living in unprecedented and difficult times. Prevention specialists, in addition to experiencing the current global pandemic, also listen to painful and distressing experiences which can lead to compassion fatigue and burnout. This presentation will help us to learn more about possible signs of burnout, how to implement self-care practices to your daily life, and receive available resources to combat the effects of work-related stress. 

 

Watch this Webinar

Supporting Prevention Efforts Through Virtual Setting: Understanding How to Leverage Telehealth for Prevention Services

This webinar supports prevention providers by highlighting tools and features of service delivery, through videoconferencing platforms. Participants will learn how to use this technology to engage in direct prevention efforts, as well as indirect prevention efforts, by supporting coalitions, caregivers, and school staff. 

 

Watch this Webinar

Supporting Prevention Efforts Through Virtual Settings: Legal and Ethical Considerations for Telehealth Prevention

This presentation reviews the legal and ethical considerations for prevention practice through a virtual setting. Participants learn which requirements must be in place as well as current changes due to COVID-19.  

 

Watch this Webinar

Where to Begin...Essential Tips for Using Videoconferencing to Deliver SUD Treatment and Recovery Services

Given recent public health concerns and the importance of social distancing, substance use disorders (SUDs) treatment and recovery support providers are seeking viable alternatives to in-person service delivery. The use of technology through a web-based videoconferencing platform in a synchronous manner (often called telehealth or telemental health) offers one solution. Recent research confirms high levels of patient satisfaction with mental health and substance abuse services delivered via videoconferencing, along with positive treatment outcomes. Most importantly, the skills and knowledge required for delivering treatment and recovery services through videoconferencing are different than those used for conducting business meetings online.  

 

Watch this Webinar

Advancing Clinicians' Videoconferencing Skills: An Audio-Consultation Series

The Mountain Plains ATTC introduces a new product based on a series of consultation groups developed to train behavioral health professionals on the use of videoconferencing to deliver clinical services. The original series, Advancing Clinicians’ Videoconferencing Skills: An Audio-Consultation Series, was developed and delivered in 2019 before the COVID-19 pandemic. Specifically, this series offered a live platform for learning and consultation related to videoconferencing case reviews, legalities and ethics, rules and regulations, and understanding clients through the lens of the evolving digital world. In addition, it explored a variety of topics and activities that promoted learning about the potential successes, challenges, and pitfalls of using videoconferencing to offer clinical services in a behavioral health setting, as well as enhancing participants’ videoconferencing skills. Highlights are now available as eleven separate audio-recorded excerpts from the original series, including the PowerPoint slides, that can be downloaded. 

 

Watch this Webinar